Insulin glargine and lixisenatide and Pioglitazone and metformin
Determining the interaction of Insulin glargine and lixisenatide and Pioglitazone and metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: Metformin and pioglitazone, Pioglitazone and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Pioglitazone and Metformin Extended-Release Tablets
- Insulin glargine and lixisenatide-Pioglitazone and Metformin Tablets
- Insulin glargine and lixisenatide-Pioglitazone Hydrochloride
- Insulin glargine and lixisenatide-Pioglitazone Tablets
- Insulin glargine and lixisenatide-Piperacillin
- Insulin glargine and lixisenatide-Piperacillin and tazobactam
- Pioglitazone and metformin-Insulin glargine and lixisenatide Subcutaneous
- Pioglitazone and metformin-Insulin glargine, recombinant Subcutaneous
- Pioglitazone and metformin-Insulin glulisine
- Pioglitazone and metformin-Insulin Glulisine (Cartridges and Pens)
- Pioglitazone and metformin-Insulin Glulisine (Vials)
- Pioglitazone and metformin-Insulin glulisine Subcutaneous